+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bupivacaine Hydrochloride for Injection Market by Route of Administration (Epidural, Local Infiltration, Peripheral Nerve Block), Concentration (0.25%, 0.5%, 0.75%), Application, End User - Global Forecast 2025-2030- Product Image
Bupivacaine Hydrochloride for Injection Market by Route of Administration (Epidural, Local Infiltration, Peripheral Nerve Block), Concentration (0.25%, 0.5%, 0.75%), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Bupivacaine Hydrochloride for Injection Market by Route of Administration (Epidural, Local Infiltration, Peripheral Nerve Block), Concentration (0.25%, 0.5%, 0.75%), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6080331
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bupivacaine hydrochloride for injection is redefining best practices in surgical and pain management protocols globally, as healthcare systems demand solutions that balance extended efficacy, patient safety, and cost efficiency. The market is moving rapidly to support these evolving needs, with both product and regulatory innovations enabling new levels of precision and adaptability for diverse end users.

Market Snapshot: Bupivacaine Hydrochloride for Injection

The bupivacaine hydrochloride for injection market is recognized as a vital segment within local anesthetics, addressing clinical demand in procedures ranging from orthopedic surgery to routine dental care. Market dynamics are characterized by robust R&D activities, ongoing regulatory evolution, and expansive adoption in developed and emerging healthcare facilities. Sustained investments in advanced drug delivery and digital monitoring tools are positioning market leaders to capture value amidst complex supply chain landscapes and rising expectations for personalized pain management. The anticipated compound annual growth rate and market size projections reflect confidence in continued sector expansion through the forecast horizon.

Scope & Segmentation of the Bupivacaine Hydrochloride Market

  • Route of Administration: Epidural (Labor and Delivery, Postoperative Pain), Local Infiltration (Dental Surgery, Surgical Wound), Peripheral Nerve Block (Continuous Catheter Block, Single Shot Block)
  • Concentration: 0.25%, 0.5%, 0.75%
  • Applications: Dental Procedures, General Surgery, Obstetrics, Orthopedic Surgery
  • End Users: Ambulatory Surgery Centers, Clinics, Hospitals
  • Geographical Coverage:
    Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina)
    Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland)
    Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Players: Pfizer Inc., Fresenius Kabi AG, AstraZeneca PLC, Hikma Pharmaceuticals PLC, Baxter International Inc., B. Braun Melsungen AG, Sandoz International GmbH, Teva Pharmaceutical Industries Ltd., Viatris Inc., Sun Pharmaceutical Industries Ltd.

Key Takeaways for Senior Decision-Makers

  • Novel delivery technologies, including liposomal encapsulation and advanced sustained-release platforms, are transforming patient outcomes by extending analgesic effects and supporting streamlined postoperative care without significant compromise on safety.
  • The regulatory ecosystem has evolved, with agencies adopting expedited approval pathways for next-generation anesthetic solutions, accelerating clinical evidence gathering and facilitating market entry for innovation-focused companies.
  • Market segmentation is increasingly nuanced, as end users from hospitals to ambulatory centers adjust procurement to leverage both low and high concentration formulations, allowing for tailored anesthesia protocols and improved throughput.
  • Regional growth patterns diverge as the Americas emphasize infrastructure and reimbursement-driven expansion, EMEA focuses on regulatory harmonization and premium solutions, and Asia-Pacific leverages rising demand tied to procedural volume and local manufacturing strengths.
  • Strategic partnerships, co-development agreements, and targeted acquisitions support competitive positioning by bridging formulation expertise with manufacturing and clinical trial capacity.
  • Supply chain flexibility and risk mitigation remain central, particularly in response to global shifts such as new tariff regimes and increased emphasis on vertical integration.

Impact of 2025 United States Tariffs on Market Dynamics

The introduction of new U.S. tariffs in 2025 directly influences supply chain architecture, with pharmaceutical and excipient sourcing strategies becoming increasingly complex. Companies have responded by reevaluating supplier portfolios, stockpiling raw materials, and in some cases, relocating production closer to target markets. Elevated tariffs are driving collaborative purchasing and longer-term contracts between manufacturers and healthcare providers, as organizations seek to ensure stability and optimize working capital allocation. Over time, these policy shifts are accelerating investments in domestic production and vertical integration, prompting industry leaders to reinforce resilience and cost control across all levels of the value chain.

Primary Keyword Focus: Bupivacaine Hydrochloride for Injection

Bupivacaine hydrochloride for injection continues to set the benchmark in local anesthetic therapy, underpinned by sustained innovation in delivery systems and robust clinical adoption. Secondary keyword integration further supports SEO objectives, bringing visibility to critical differentiators for decision-makers.

Methodology & Data Sources

This research draws on primary interviews with executives, clinical stakeholders, and supply chain managers, alongside comprehensive secondary analysis from peer-reviewed journals, regulatory filings, and industry databases. Findings are validated by advisory panels, ensuring accuracy and actionable insight.

Why This Report Matters

  • Supports data-driven strategy decisions through actionable, rigorously sourced market insights.
  • Enables senior leaders to quantify and benchmark innovation trends, regulatory risks, and evolving partnership ecosystems.
  • Empowers procurement and product teams with current, granular intelligence on end-user demands and regional market forces.

Conclusion

The bupivacaine hydrochloride for injection market is navigating a pivotal period marked by technological breakthroughs, regulatory shifts, and evolving customer demand. Stakeholders equipped with this analysis will be well positioned to drive differentiated growth and sustained clinical success.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of liposomal bupivacaine formulations for extended-release postsurgical pain management
5.2. Rising demand for ultrasound-guided peripheral nerve blocks in ambulatory surgical settings leveraging bupivacaine injections
5.3. Expansion of nonopioid multimodal analgesia protocols boosting bupivacaine use in enhanced recovery after surgery pathways
5.4. Intensifying competition from generic manufacturers driving significant price erosion in the bupivacaine injection segment
5.5. Increasing regulatory approvals of preservative-free bupivacaine hydrochloride solutions to reduce adverse obstetric analgesia events
5.6. Technological advancements in drug delivery such as biodegradable extended-release implants for orthopedic bupivacaine administration
5.7. Surge in demand for bupivacaine injections in minimally invasive laparoscopic procedures enhancing postoperative pain control
5.8. Development of prefilled safety syringes for precise dosing amid regulatory scrutiny over injection accuracy and patient safety
5.9. Rising investment in clinical research exploring novel bupivacaine and adjuvant combinations for prolonged analgesic efficacy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bupivacaine Hydrochloride for Injection Market, by Route Of Administration
8.1. Introduction
8.2. Epidural
8.2.1. Labor And Delivery
8.2.2. Postoperative Pain
8.3. Local Infiltration
8.3.1. Dental Surgery
8.3.2. Surgical Wound
8.4. Peripheral Nerve Block
8.4.1. Continuous Catheter Block
8.4.2. Single Shot Block
9. Bupivacaine Hydrochloride for Injection Market, by Concentration
9.1. Introduction
9.2. 0.25%
9.3. 0.5%
9.4. 0.75%
10. Bupivacaine Hydrochloride for Injection Market, by Application
10.1. Introduction
10.2. Dental Procedures
10.3. General Surgery
10.4. Obstetrics
10.5. Orthopedic Surgery
11. Bupivacaine Hydrochloride for Injection Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Clinics
11.4. Hospitals
12. Americas Bupivacaine Hydrochloride for Injection Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bupivacaine Hydrochloride for Injection Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bupivacaine Hydrochloride for Injection Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Pfizer Inc.
15.3.2. Fresenius Kabi AG
15.3.3. AstraZeneca PLC
15.3.4. Hikma Pharmaceuticals PLC
15.3.5. Baxter International Inc.
15.3.6. B. Braun Melsungen AG
15.3.7. Sandoz International GmbH
15.3.8. Teva Pharmaceutical Industries Ltd.
15.3.9. Viatris Inc.
15.3.10. Sun Pharmaceutical Industries Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHAI
FIGURE 24. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHSTATISTICS
FIGURE 25. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHCONTACTS
FIGURE 26. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LABOR AND DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LABOR AND DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SURGICAL WOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SURGICAL WOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONTINUOUS CATHETER BLOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONTINUOUS CATHETER BLOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SINGLE SHOT BLOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY SINGLE SHOT BLOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 0.25%, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 0.25%, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 0.5%, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 0.5%, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 0.75%, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY 0.75%, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY OBSTETRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY OBSTETRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 96. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 97. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 100. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 101. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. CANADA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 110. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 111. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 112. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 113. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 114. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 115. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 182. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 183. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 184. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 185. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 186. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 187. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 188. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 189. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. GERMANY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 196. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 197. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 198. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 199. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 200. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 201. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 202. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 203. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. FRANCE BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 224. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 225. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 226. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 227. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 228. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 229. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 230. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 231. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ITALY BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 238. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 239. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 240. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 241. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 242. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 243. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 244. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 245. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. SPAIN BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY EPIDURAL, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY LOCAL INFILTRATION, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY PERIPHERAL NERVE BLOCK, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY CONCENTRATION, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BUPIVACAINE HYDROCHLORIDE FOR INJECTION MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bupivacaine Hydrochloride for Injection market report include:
  • Pfizer Inc.
  • Fresenius Kabi AG
  • AstraZeneca PLC
  • Hikma Pharmaceuticals PLC
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.

Related Topics

Related Reports

Bupivacaine Hydrochloride (CAS 18010-40-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Bupivacaine Hydrochloride (CAS 18010-40-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Bupivacaine Liposome Injection Market by End Use (Ambulatory Surgery Centers, Clinics, Hospitals), Indication (Postoperative Pain Management, Regional Anesthesia), Application, Distribution Channel, Patient Type, Product Type, Packaging - Global Forecast 2025-2030 - Product Image

Bupivacaine Liposome Injection Market by End Use (Ambulatory Surgery Centers, Clinics, Hospitals), Indication (Postoperative Pain Management, Regional Anesthesia), Application, Distribution Channel, Patient Type, Product Type, Packaging - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030 - Product Image

Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030

  • Report
  • 245 Pages
  • Global
From
Bromisovale & Procaine Injection Market by End User (Ambulatory Surgical Center, Clinic, Dental Clinic), Distribution Channel (Direct Tender, Hospital Pharmacy, Online Pharmacy), Product Type, Active Ingredient, Application - Global Forecast 2025-2030 - Product Image

Bromisovale & Procaine Injection Market by End User (Ambulatory Surgical Center, Clinic, Dental Clinic), Distribution Channel (Direct Tender, Hospital Pharmacy, Online Pharmacy), Product Type, Active Ingredient, Application - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Facet-Joint Injection Global Market Report 2025 - Product Image

Facet-Joint Injection Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.